Apoe4-AGE Axis Is Linked To Mtdna Release And Cgas-STING-Mediated Neuroinflammation In The Aging Brain
Our brains undergo many changes as we age, and understanding these changes is crucial for tackling age-related diseases like Alzheimer’s. Recent research sheds light on a critical pathway that contributes to brain inflammation, particularly in individuals with a specific genetic predisposition. It turns out that a gene known to significantly increase the risk of Alzheimer’s is associated with a greater buildup of certain harmful molecules in the aging brain. These molecules, called Advanced Glycation End-products (AGEs), are essentially sugar-protein complexes that can accumulate over time. When these AGEs build up, they seem to cause problems within the brain’s cells, specifically affecting the mitochondria – the powerhouses of our cells. This disruption leads to the release of mitochondrial DNA, which normally stays safely inside the mitochondria, out into the cell’s main compartment. Once this mitochondrial DNA is outside its usual place, it acts as a danger signal, activating a crucial immune pathway known as cGAS-STING. Think of cGAS-STING as an alarm system that, when triggered, initiates an inflammatory response. In the brain, this leads to increased inflammation, particularly in specialized immune cells called microglia. While microglia usually protect the brain, chronic activation of this inflammatory pathway can be detrimental, contributing to neurodegeneration. The good news is that this research also points to potential new avenues for treatment. By targeting the receptor for these AGEs (called RAGE), or by interfering with the cGAS-STING pathway itself, scientists were able to reduce mitochondrial problems and Alzheimer’s-like symptoms in animal models. This suggests that blocking this inflammatory cascade could be a promising strategy to protect the aging brain, especially for those with the APOE4 genetic risk factor.
Source: link to paper